Clinical Trial Update: Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tranilast in combination with allopurinol for moderate to severe gout with hyperuricemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• Allopurinol (Allopurinol)
• Tranilast (tranilast)

Snippet

Sponsor: Nuon Therapeutics, Inc. | Conditions: Moderate to Severe Gout, Hyperuricemia | Phase 2 | Status: COMPLETED